Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit

被引：0

作者：

Borucki, Robert ^{[1
,2
]}

Concha, Josef Symon S. ^{[1
,2
]}

Burroughs, Julie ^{[1
,2
]}

Okawa, Joyce ^{[1
,2
]}

Werth, Victoria P. ^{[1
,2
,3
]}

机构：

[1] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA USA

[2] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA

[3] Perelman Ctr Adv Med, Dept Dermatol, Suite 1-330A,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA

来源：

JAAD INTERNATIONAL | 2021年 / 2卷

基金：

美国国家卫生研究院;

关键词：

clinical trials; COVID-19; cutaneous lupus erythematosus; dermatomyositis; novel therapies; teledermatology;

D O I：

10.1016/j.jdin.2020.11.002

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The impact of the novel COVID-19 has diverted research efforts to COVID-19, leaving other research without clear plans of how to continue safely and effectively. This was the case in interventional clinical trials unrelated to COVID-19, a vital component in bringing much needed new medications to patients. These trials should be continued if they can be completed safely, not only for good data and potential approval of needed treatments but because enrolled patients may have a worsening disease without access to care. With COVID-19 case numbers increasing in many areas worldwide, it is more important than ever to analyze burden.

引用

页码：94 / 95

页数：2

共 3 条

[1]

Berg SA, 2017, SARCOIDOSIS VASC DIF, V34, P165, DOI 10.36141/svdld.v34i2.5434

[2] Quality of life in cutaneous lupus erythematosus [J].

Klein, Rachel ;

Moghadam-Kia, Siamak ;

Taylor, Lynne ;

Coley, Christopher ;

Okawa, Joyce ;

LoMonico, Jonathan ;

Chren, Mary-Margaret ;

Werth, Victoria P. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (05) :849-858

[3] Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic [J].

Tan, Aaron C. ;

Ashley, David M. ;

Khasraw, Mustafa .

CLINICAL CANCER RESEARCH, 2020, 26 (13) :3100-3103

← 1 →